Alpa Laboratories IPO
Alpa Laboratories IPO — date, price band, lot size & details 2007
Alpa Laboratories listed on 6 Aug 2007 at ₹61, 10.3% below the ₹68 issue price.
Alpa Laboratories is an Indore based maker of ethical, generic, over the counter and veterinary medicines, sold under the Alpa brand and made for other drug companies. Its total income was Rs 101.81 crore in FY2007.
Stock price
Alpa Laboratories is listed — here is the live share price.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Timetable
Key dates from opening to listing. Today is 12 November.
- Open 12 Jul 2007
- Close 17 Jul 2007
- Allotment 27 Jul 2007
- Refund/credit TBA
- Listing 06 Aug 2007
Issue summary
The terms of the offer, as filed.
| IPO Dates | 12 to 17 Jul, 2007 |
|---|---|
| Price Band | ₹62 – ₹68 |
| Face Value | ₹10 |
| Lot Size | 100 Shares |
| Issue Size | ₹61.07 Cr |
| Sale Type | Fresh capital only |
| Listing On | BSE, NSE |
| Registrar | Bigshare Services Private Limited |
| Min Investment | ₹ 6,800 |
Share of the offer set aside for each investor category, as stated in the offer document.
What will it cost me?
Bidding is in multiples of 100 shares at the ₹68 cut-off. Drag to size your application.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 100 | ₹6,800 |
| Retail (max) | 29 | 2,900 | ₹1,97,200 |
| S-HNI (min) | 30 | 3,000 | ₹2,04,000 |
| S-HNI (max) | 147 | 14,700 | ₹9,99,600 |
| B-HNI (min) | 148 | 14,800 | ₹10,06,400 |
Strengths & risks
Drawn from the offer document — the case for and against, side by side.
Strengths · 4
- 01Total income rose from Rs 38.49 crore in FY2005 to Rs 101.81 crore in FY2007.
- 02Profit after tax rose from Rs 1.47 crore in FY2005 to Rs 6.40 crore in FY2007.
- 03Net worth rose from Rs 7.46 crore in FY2005 to Rs 26.85 crore in FY2007.
- 04It made medicines for well known companies such as Cipla, Lupin and Glenmark; return on net worth was 23.57%.
Risks · 5
- 01Profit after tax was only Rs 6.40 crore on income of Rs 101.81 crore in FY2007, so margins were thin.
- 02The Alpa trade mark used on its own products is registered in the name of Alpa Labs (India), a promoter group company, not the company, which was incorporated in 1988.
- 03Contract manufacturing for other brands can move to rival makers; Rs 87.60 crore was planned for a new plant at Pigdamber.
- 04Exports to countries in Africa and elsewhere bring currency and payment risk; Rs 30.64 crore was for working capital margin.
- 05Promoter and promoter group holding fell from 88.90% before the issue to 49.73% after it.
Three years of numbers
All figures in ₹ crore, as reported in the Alpa Laboratories offer document.
| Metric | 31 Mar 2007 | 31 Mar 2006 | 31 Mar 2005 |
|---|---|---|---|
| Total Income | 101.81 | 71.25 | 38.49 |
| Profit After Tax | 6.40 | 4.12 | 1.47 |
| NET Worth | 26.85 | 17.66 | 7.46 |
See how this IPO compares — view listing performance of all mainboard IPOs.
Valuation & key ratios
Ratios are for the latest full financial year reported in the Alpa Laboratories RHP.
Where the money goes
₹130.08 Cr of the issue is earmarked to named objects.
About the company
It makes ethical drugs, generic drugs, over the counter products and veterinary products in several dosage forms and sells them under the Alpa trade mark, which is registered in the name of a promoter group company.
It also makes formulations under their own brands for other drug companies such as Cipla, Zydus Cadila, Lupin and Glenmark, and exports to countries including the Philippines, Kenya, Ghana and Nigeria.
The IPO was Rs 61.07 crore and was entirely a fresh issue at Rs 68, the top of the Rs 62 to Rs 68 band. The money was mainly for a new plant at Pigdamber, Indore and for working capital margin.
Interested in this IPO? Check the live subscription status or browse all upcoming mainboard IPOs.
The bankers & the filings
Who is running the book, and the documents this page is built from.
Alpa Laboratories IPO Documents
Read the filings this page is built from.
Lead Manager Track Record
How the book-running lead managers on this issue have priced their past IPOs, measured on listing day.
Almondz Global Securities Ltd
23 issues handledBest listing: Amar Remedies (+100.0%). Weakest: First Winner Industries (-12.0%).
Listing gain compares the listing-day opening price with the issue price, using the IPOs on IPO Guru that this lead manager has taken to market. A strong record reflects how the banker has priced past issues — it is not a forecast for this one. See every issue they have handled on the lead managers page.
Company contact
Frequently asked
What is the GMP of Alpa Laboratories?
The current Grey Market Premium is ₹0.
What is the Alpa Laboratories IPO price band?
₹62 to ₹68, on a face value of ₹10.
When is the allotment?
The basis of allotment is 27 July 2007, with listing on 6 August 2007.
How do I check allotment status?
On the IPO Guru allotment page or on the registrar's site — Bigshare Services Private Limited.
Every number here traces back to a filing.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Every number on this page is sourced from the RHP, BSE & NSE.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
